Prevalence of wild-type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: Results of the Amylo-VIP-HF study.

Alwin TubbenHendrea S A TingenNiek H J PrakkenVanessa P M van EmpelThomas M GorterLaura M G MeemsOlivier C ManintveldMichiel RienstraRobert G TielemanAndor W J M GlaudemansDirk J van VeldhuisenRiemer H J A SlartHans L A NienhuisPeter van der Meer

Published in: European journal of heart failure (2024)

Keyphrases

wild type
heart failure
risk factors
acute heart failure
left ventricular
atrial fibrillation
multiple myeloma
cardiac resynchronization therapy